Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when ...
AbbVie Inc. (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD) are two of the world's biggest biotech stocks. However, their sales have been heading in different directions and each has offered up very different forecasts for 2018. Given that these titans are ...
Madison.com · 3mon
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it under the ...
The GILD stock price today sits 24% higher than it did as recently as June, when the stock hit a three-year low. There is some good news here. As InvestorPlace’s Chris Lau pointed out, the acquisition of Kite Pharma and its CAR-T therapy makes some sense ...
InvestorPlace · 6mon
Gilead Sciences, Inc. (NASDAQ:GILD) has put together a nice run of late. The GILD stock price today sits 24% higher than it did as recently as June, when the stock hit a three-year low. There is some good news here. As InvestorPlace’s Chris Lau pointed ...
Yahoo Finance · 6mon
Given the competitive threats, Baird dismissed Gilead's move into oncology as "incrementally negative" for the stock. Mizuho Securities did a quick straw poll of investors and concluded that "60% of respondents believe Gilead overpaid for Kite," while ...
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one high-profile Wall Street pick and putting it under the ...
With nothing more than a quick view of its chart and a passing glance at the headlines, it would be easy to decide Gilead Sciences, Inc. (NASDAQ:GILD) is best left avoided. The GILD stock price took a fairly big tumble after the release of its third ...
Yahoo Sports · 6mon